ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Eight Firms Join AACR As Sustaining Members

April 25, 1997

NCI brings in grantees to explain their work, promise of nanotech, to advisory board.

July 16, 2004

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

Upton Briefed On Problems; To Start July 25

July 15, 1977